Loading viewer...
investor_presentation
Format: PDF investor_presentation
CohBar's Q4 Investor Presentation highlights breakthrough mitochondrial science and novel therapeutics, focusing on clinical trials and future growth potential.
Yatsen Holding Q1 2022 Investor Presentation
investor_presentationinvestor_presentation
14 Pages
Yatsen Holding Limited
investor_presentation
Kraft-Heinz
investor_presentation
Freshii